First National Consensus on Chronic Hepatitis B

This is the first time in our country that a group of experts in the field of hepatology gather to review the current status of HBV infection establishing the First National Consensus on Chronic Hepatitis B. With the new sensitive diagnostic methods, new antivirals capable of inhibiting viral replication, the appropriate use of passive and active immunoprophilaxis, and the better understanding of the natural history of the disease, we are finding new corners in the approach of high risk groups and management of infected patients. The National Consensus on Chronic Hepatitis B reunited 34 Mexican leaders in Hepatology, Gastroenterology, Infectology, Pediatrics, Oncology, Pathology and Molecular Biology. During these rounds the need of incorporating new knowledge on Hepatitis B in our daily clinical practice was analyzed in a way to transform Hepatitis B to an understandable and easy subject. Also, the fears on the knowledge of basic molecular biology, practical analysis of serologic markers, and diagnostic methodology as well as use and indications for new therapeutic agents was also discussed. This is a first consensus.